- 801. fertility promoting drug
- [drugs used to increase fertility or to treat infertility in either males or females. ( CSP )] (UMLS (CSP) C0015896) =Pharmacologic Substance ;
=Drug;
=2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine;
| - 851. FETAL BLOOD SAMPLE/BX
- [ ] (UMLS (ICD9CM) C0177285) =Diagnostic Procedure
|
- 802. Fertility Study
- (UMLS (NCI) C0200069) =Diagnostic Procedure
| - 852. fetal cell culture
- [ ] (UMLS (CSP) C0920515) fetus cell culture =Laboratory Procedure
|
- 803. FERTILITY TESTING
- (UMLS (ICD9CM) C0886496) =Finding
| - 853. FETAL DAMG D/T DRUG-UNSP
- [ ] (UMLS (ICD9CM) C0157085) =Disease or Syndrome
|
- 804. Fertility/Fertilization
- [fusion of a spermatozoan with an ovum resulting in the formation of a zygote. ( CSP )] (UMLS (NCI) C0015914) =Organism Function ;
=fecundity;
=in vitro Fertilization;
artificial fertilization | - 854. Fetal death from asphyxia or anoxia before onset of labor or at unspecified time
- [ ] (UMLS (ICD9CM) C0270131) =Injury or Poisoning
|
- 805. Fertiral
- (UMLS (NCI) C0591507) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 855. fetal diagnosis
- [ ] (UMLS (CSP) C0599190) =Diagnostic Procedure ;
|
- 806. Ferumoxsil
- [A silicon-coated iron oxide, and a superparamagnetic contrast agent used in magnetic resonance imaging (MRI). After oral administration, ferumoxsil moves through and occupies the stomach and intestines. During MRI, ferumoxsil generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures. This allows visualization of adjacent abdominal tissues. ( NCI )] (UMLS (NCI) C0257928) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =oxide;
siloxane;
[TN401] IRON;
[DX900] DIAGNOSTICS, OTHER =ferumoxsil 0.175 MG/ML | - 856. FETAL DISPRO NOS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0156987) =Disease or Syndrome ;
|
- 807. Ferumoxtran-10
- [A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent. (NCI04) ( NCI )] (UMLS (NCI) C0386370) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 857. FETAL DISPROP NOS-DELIV
- [ ] (UMLS (ICD9CM) C0156986) =Disease or Syndrome ;
|
- 808. Ferumoxytol
- [A superparamagnetic iron oxide nanoparticle coated with a low molecular weight semi-synthetic carbohydrate, polyglucose sorbitol carboxymethyl ether, with potential anti-anemic and imaging properties. After intravenous administration, ferumoxytol replaces iron stores with fewer side effects compared to the use of oral iron. In addition, this agent generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures in magnetic resonance imaging (MRI). Due to small particle size, ferumoxytol remains in the intravasculature for a prolonged period and so may be used as a blood pool agent. (NCI05) ( NCI )] (UMLS (NCI) C1453192) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 858. FETAL DISPROP NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0156985) =Disease or Syndrome ;
|
- 809. FES
- [Human Oncogene FPS-FES is a mutated variant of FES Gene (FES/FPS Subfamily), which encodes 822 aa 93-kDa Tyrosine-Protein Kinase FES/FPS, a tyrosine-specific protein kinase involved in normal hematopoiesis and containing an FCH and SH2 domain. The FES chromosomal location is linked to a translocation identified in patients with acute promyelocytic leukemia. A truncated transcript is generated utilizing a start site in a far downstream exon. Oncogene FPS-FES disrupts normal cell function. ( NCI )] (UMLS (NCI) C0812383) FPS;
Fujinami Sarcoma Virus and Feline Sarcoma Virus Transforming Gene;
Oncogene FES;
Oncogene FPS-FES =Gene or Genome ;
| - 859. Fetal distress affecting management of mother
- (UMLS (ICD9CM) C0015931) =Disease or Syndrome ;
|
- 810. FET DAMAG D/T DRUG-DELIV
- [ ] (UMLS (ICD9CM) C0157086) =Disease or Syndrome
| - 860. Fetal distress first noted during labor and delivery, in liveborn infant
- [ ] (UMLS (ICD9CM) C1719625) FETAL DISTRS DUR LAB/DEL =Pathologic Function
|
- 811. FET DAMG D/T DIS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157083) =Disease or Syndrome
| - 861. FETAL DISTRESS NOS
- [ ] (UMLS (ICD9CM) C0270124) =Disease or Syndrome
|
- 812. FET DAMG D/T DIS-DELIVER
- [ ] (UMLS (ICD9CM) C0157082) =Disease or Syndrome
| - 862. Fetal distress, affecting management of mother, antepartum
- [ ] (UMLS (ICD9CM) C0157114) =Disease or Syndrome
|
- 813. FET DAMG D/T DIS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157081) =Disease or Syndrome
| - 863. Fetal distress, affecting management of mother, delivered
- [ ] (UMLS (ICD9CM) C0157113) =Disease or Syndrome
|
- 814. FET DAMG D/T DRUG-ANTEPA
- [ ] (UMLS (ICD9CM) C0157087) =Disease or Syndrome
| - 864. Fetal distress, affecting management of mother, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0157112) =Disease or Syndrome
|
- 815. FET DAMG D/T VIRUS-ANTEP
- [ ] (UMLS (ICD9CM) C0157079) =Disease or Syndrome
| - 865. FETAL EKG
- [ ] (UMLS (ICD9CM) C0177284) =Diagnostic Procedure
|
- 816. FET DAMG D/T VIRUS-DELIV
- [ ] (UMLS (ICD9CM) C0157078) =Disease or Syndrome
| - 866. Fetal Heart
- [The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time. ( MSH )] (UMLS (NCI) C0015935) =Embryonic Structure ;
|
- 817. FET DAMG D/T VIRUS-UNSP
- [ ] (UMLS (ICD9CM) C0157077) =Disease or Syndrome
| - 867. fetal hemoglobin
- [fetal hemoglobin; major component of hemoglobin in the fetus; it has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. ( CSP )] (UMLS (CSP) C0015936) =Amino Acid, Peptide, or Protein; Biologically Active Substance =hemoglobin;
embryo/fetus protein |
- 818. FET DEATH-ANOXIA DUR LAB
- [ ] (UMLS (ICD9CM) C0158928) =Pathologic Function
| - 868. fetal hypoxia
- [Hypoxia in utero, caused by conditions such as inadequate placental function (often abruptio placentae), preeclamptic toxicity, prolapse of the umbilical cord, or complications from anesthetic administration. ( NCI )] (UMLS (CSP) C0349489) =Disease or Syndrome
|
- 819. FET DISTRESS BEFOR LABOR
- [ ] (UMLS (ICD9CM) C0158929) =Pathologic Function
| - 869. fetal infection
- [ ] (UMLS (CSP) C1397629) =Disease or Syndrome
|
- 820. FET GROWTH RET 2500+G
- [ ] (UMLS (ICD9CM) C0158891) =Disease or Syndrome
| - 870. Fetal Lipomatosis
- [A benign disorder characterized by the presence of multiple lipoblastomas. ( NCI )] (UMLS (NCI) C0334475) =Neoplastic Process
|
- 821. FET GROWTH RET 500-749G
- [ ] (UMLS (ICD9CM) C0158884) =Disease or Syndrome
| - 871. fetal macrosomatia
- [ ] (UMLS (CSP) C0599193) =Congenital Abnormality; Disease or Syndrome
|
- 822. FET GROWTH RET 750-999G
- [ ] (UMLS (ICD9CM) C0158885) =Disease or Syndrome
| - 872. fetal macrosomia
- [A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus. ( MSH )] (UMLS (CSP) C0015938) =Disease or Syndrome ;
=embryo/fetus disorder;
Diabetes mellitus, antepartum;
Diabetes in Pregnancy;
|
- 823. FET GROWTH RETARD
- [ ] (UMLS (ICD9CM) C0158883) =Disease or Syndrome
| - 873. FETAL MAL 1000-1249G
- [ ] (UMLS (ICD9CM) C0158876) =Disease or Syndrome
|
- 824. FET GROWTH RETARD WTNOS
- [abnormal fetal physical growth or growth potential at any gestational stage. ( CSP )] (UMLS (ICD9CM) C0015934) =Pathologic Function ;
=embryo/fetus disorder;
Growth Disorders;
developmental disease/disorder;
| - 874. FETAL MAL 1250-1499G
- [ ] (UMLS (ICD9CM) C0158877) =Disease or Syndrome
|
- 825. FET GRWTH RET 1000-1249G
- [ ] (UMLS (ICD9CM) C0158886) =Disease or Syndrome
| - 875. FETAL MAL 1500-1749G
- [ ] (UMLS (ICD9CM) C0158878) =Disease or Syndrome
|
- 826. FET GRWTH RET 1250-1499G
- [ ] (UMLS (ICD9CM) C0158887) =Disease or Syndrome
| - 876. FETAL MAL 750-999G
- [ ] (UMLS (ICD9CM) C0158875) =Disease or Syndrome
|
- 827. FET GRWTH RET 1500-1749G
- [ ] (UMLS (ICD9CM) C0158888) =Disease or Syndrome
| - 877. FETAL MALNUTR 1750-1999G
- [ ] (UMLS (ICD9CM) C0158879) =Disease or Syndrome
|
- 828. FET GRWTH RET 1750-1999G
- [ ] (UMLS (ICD9CM) C0158889) =Disease or Syndrome
| - 878. FETAL MALNUTR 2000-2499G
- [ ] (UMLS (ICD9CM) C0158880) =Disease or Syndrome
|
- 829. FET GRWTH RET 2000-2499G
- [ ] (UMLS (ICD9CM) C0158890) =Disease or Syndrome
| - 879. FETAL MALNUTR 2500+G
- [ ] (UMLS (ICD9CM) C0158881) =Disease or Syndrome
|
- 830. FET/PLAC PROB NEC-ANTEPA
- [ ] (UMLS (ICD9CM) C0157133) =Disease or Syndrome
| - 880. FETAL MALNUTR 500-749G
- [ ] (UMLS (ICD9CM) C0158874) =Disease or Syndrome
|
- 831. FET/PLAC PROB NEC-DELIV
- [ ] (UMLS (ICD9CM) C0157132) =Disease or Syndrome
| - 881. FETAL MALNUTRITION
- [ ] (UMLS (ICD9CM) C0158873) =Disease or Syndrome
|
- 832. FET/PLAC PROB NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0157131) =Disease or Syndrome
| - 882. Fetal malnutrition without mention of "light-for-dates"
- [ ] (UMLS (ICD9CM) C1510504) =Disease or Syndrome ;
|
- 833. FET/PLAC PROB NOS-ANTEPA
- [ ] (UMLS (ICD9CM) C0157137) =Disease or Syndrome
| - 883. Fetal malnutrition without mention of "light-for-dates", unspecified [weight]
- [ ] (UMLS (ICD9CM) C0158872) =Disease or Syndrome
|
- 834. FET/PLAC PROB NOS-DELIV
- [ ] (UMLS (ICD9CM) C0157136) =Disease or Syndrome
| - 884. fetal monitoring
- [Physiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery. ( MSH )] (UMLS (CSP) C0015945) =Diagnostic Procedure
|
- 835. FET/PLAC PROB NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157135) =Disease or Syndrome
| - 885. fetal neoplasm
- [ ] (UMLS (CSP) C0598366) =Neoplastic Process ;
|
- 836. fetal
- [ ] (UMLS (CSP) C0521457) =Functional Concept
| - 886. fetal nutrition
- [ ] (UMLS (CSP) C0598900) =Organism Attribute ;
|
- 837. Fetal
- [(FEET-us) The developing offspring from 7 to 8 weeks after conception until birth. ( NCI )] (UMLS (NCI) C0015965) =Embryonic Structure =Body Part;
| - 887. FETAL OPS-FACILITATE DEL
- (UMLS (ICD9CM) C0846357) Operations on fetus to facilitate delivery;
=Therapeutic or Preventive Procedure |
- 838. FETAL & NEWBORN ASP NOS
- [ ] (UMLS (ICD9CM) C1561791) Fetal and newborn aspiration, unspecified;
=Pathologic Function | - 888. fetal protein
- [ ] (UMLS (CSP) C0015950) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 839. Fetal -Epithelial Differentiation
- (UMLS (NCI) C1333607) =Finding
| - 889. FETAL PULSE OXIMETRY
- [ ] (UMLS (ICD9CM) C0994541) =Diagnostic Procedure
|
- 840. FETAL ABNORM NEC-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157095) =Disease or Syndrome
| - 890. Fetal Rhabdomyoma
- [A rare benign mesenchymal neoplasm arising from skeletal muscle. It is characterized by the presence of immature spindle and polygonal cells within a scant myxoid stroma. It usually develops in the head and neck region of young children. ( NCI )] (UMLS (NCI) C0334482) =Neoplastic Process
|
- 841. FETAL ABNORM NEC-DELIVER
- [ ] (UMLS (ICD9CM) C0157094) =Disease or Syndrome
| - 891. fetal rickets
- [ ] (UMLS (CSP) C0242080) =Disease or Syndrome
|
- 842. FETAL ABNORM NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0157093) =Disease or Syndrome
| - 892. fetal stress
- [ ] (UMLS (CSP) C0456057) =Pathologic Function =stress;
|
- 843. FETAL ABNORM NOS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157099) =Disease or Syndrome
| - 893. fetal surgery
- [ ] (UMLS (CSP) C1261465) fetus surgery;
=Therapeutic or Preventive Procedure ;
|
- 844. FETAL ABNORM NOS-DELIVER
- [ ] (UMLS (ICD9CM) C0157098) =Disease or Syndrome
| - 894. fetal tissue
- [Any tissue from a fetus. ( NCI )] (UMLS (CSP) C0242291) =Tissue
|
- 845. FETAL ABNORM NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157097) =Disease or Syndrome
| - 895. fetal tissue transplantation
- [Transference of fetal tissue between individuals of the same species or between individuals of different species. ( MSH )] (UMLS (CSP) C0079345) =Therapeutic or Preventive Procedure ;
|
- 846. Fetal Adenoma
- [A thyroid gland adenoma composed of microfollicular structures. (NCI05) ( NCI )] (UMLS (NCI) C0334328) =Neoplastic Process
| - 896. FETAL-MATERN HEM-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157104) =Disease or Syndrome
|
- 847. Fetal and neonatal hemorrhage
- [ ] (UMLS (ICD9CM) C0473800) =Pathologic Function
| - 897. FETAL-MATERNAL HEM-DELIV
- [ ] (UMLS (ICD9CM) C0157103) =Disease or Syndrome
|
- 848. Fetal and newborn aspiration
- [ ] (UMLS (ICD9CM) C1561805) =Pathologic Function
| - 898. Fetal-maternal hemorrhage affecting management of mother
- [ ] (UMLS (ICD9CM) C0157101) =Disease or Syndrome
|
- 849. fetal blood
- [Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. ( MSH )] (UMLS (CSP) C0015925) =Tissue ;
| - 899. Fetal-maternal hemorrhage, unspecified as to episode of care in pregnancy
- [Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) ( MSH )] (UMLS (ICD9CM) C0015959) =Pathologic Function =Anemia, Neonatal;
|
- 850. Fetal blood loss
- [ ] (UMLS (ICD9CM) C0158951) =Disease or Syndrome ;
| - 900. FETAL/NEONATAL HEPATITIS
- [ ] (UMLS (ICD9CM) C0158976) =Disease or Syndrome ;
|
home 
Armenian-English 
top